Characterization of Chemoresistant Cell Populations Improves Risk Stratification and Therapy Prediction in Pediatric...

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Pediatric acute myeloid leukemia (pAML) has high relapse rates despite chemotherapy.
• Current prognostic tools lack precision for identifying high-risk patients.
• Aggressive treatments like stem cell transplantation (SCT) carry significant toxicity.

Purpose of the Study:

• To develop a more accurate early risk prediction model for pAML.
• To identify novel biomarkers for chemoresistance in pAML.
• To uncover potential therapeutic targets for high-risk pAML.

Main Methods:

• Single-cell resolution analysis of paired diagnosis-relapse samples from 33 pAML patients.
• Development of a risk prediction model incorporating chemoresistant cell populations.
• Molecular characterization of identified chemoresistant cells.

Main Results:

• Chemoresistant cell populations at diagnosis significantly improved pAML risk prediction.
• A previously unrecognized high-risk subgroup (20% of cases) with <40% event-free survival was identified.
• This subgroup accounted for 50% of deaths in patients not receiving SCT at first remission.

Conclusions:

• Early detection of chemoresistant cells refines pAML risk stratification.
• Identification of chemoresistant cells reveals potential therapeutic targets for high-risk pAML.
• Improved risk prediction can guide personalized treatment strategies and improve outcomes for pediatric acute myeloid leukemia patients.